Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Oncogene|July 22, 1998
Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healingV Ankoma-Sey, M Matli, K B Chang, et al.
The Journal of Surgical Research|March 1, 1990
A model of reversible obstructive jaundice in the ratM C Posner, M E Burt, M D Stone, et al.
The Journal of Biological Chemistry|February 29, 2000
VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factorL W Wu, L D Mayo, J D Dunbar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancerR Dienstmann, G Villacampa, A Sveen, et al.
The Journal of Biological Chemistry|February 15, 2000
Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferationL W Wu, L D Mayo, J D Dunbar, et al.
Diseases of the Colon and Rectum|March 25, 2000
Angiogenesis, proliferation, and apoptosis in anal high-grade squamous intraepithelial lesionsV R Litle, J D Leavenworth, T M Darragh, et al.
Journal of the National Cancer Institute|March 20, 1991
Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancerR J Stagg, A P Venook, J L Chase, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancerP B Chapman, T J Lester, E S Casper, et al.
Cancer Research|June 15, 1997
Mutations of the PATCHED gene in several types of sporadic extracutaneous tumorsJ Xie, R L Johnson, X Zhang, et al.
The Journal of Biological Chemistry|February 7, 2001
Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferationD Q Guo, L W Wu, J D Dunbar, et al.
Pageof 5